Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Gynecol Oncol. 2013 Oct 4;131(3):535–540. doi: 10.1016/j.ygyno.2013.09.032

Table 1.

Patient Demographics

n (%)
Age
 Mean (min-max) 61.5 (31–86)

Stage
 I/II 1 (2.9)
 III 27 (79.4)
 IV 6 (17.6)

Histology
 Serous 24 (70.6)
 Endometrioid 2 (5.9)
 Mixed 3 (8.8)
 Other 5 (14.7)

Tumor Grade
 1 3 (8.8)
 2 1 (2.9)
 3 30 (88.2)

Pathologic Diagnosis
 Ovarian 27 (79.4)
 Fallopian tube 1 (2.9)
 Primary peritoneal 6 (17.6)

Performance Status
 0 22 (64.7)
 1 12 (35.3)
Prior # Chemotherapy Regimens
 1 20 (58.8)
 2 14 (41.2)

Platinum-free Interval
 <6 months 12 (35.2)
 6–12 months 11 (32.4)
 >12 months 11 (32.4)